FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Elvitegravir (VITEKTA) Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Gilead Sciences, Inc. (New 11/23/2016)

Company Contact Information:
800-445-3235

Presentation Posting Date Related Information
VITEKTA® (elvitegravir) Tablets, 85 mg, Bottles of 30 (NDC 61958-1301-1) 10/20/2016 Gilead Sciences, Inc has made a business decision to permanently discontinue manufacture of this drug product. Discontinuation of product manufacture is not related to product safety or efficacy.
VITEKTA® (elvitegravir) Tablets, 150 mg, Bottles of 30 (NDC 61958-1302-1) 10/20/2016 Gilead Sciences, Inc has made a business decision to permanently discontinue manufacture of this drug product. Discontinuation of product manufacture is not related to product safety or efficacy.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English